Premium
EyePoint Pharmaceuticals Inc (EYPT)
NASDAQ
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on us... EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert and Verisome Technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.345 | 5.60519902518 | 6.155 | 7.59 | 6.04 | 722218 | 6.44864825 | CS |
| 4 | -1.3 | -16.6666666667 | 7.8 | 8.7952 | 5.9 | 904234 | 7.17847935 | CS |
| 12 | -2.65 | -28.9617486339 | 9.15 | 9.4999 | 5.9 | 864570 | 7.64094974 | CS |
| 26 | -1.46 | -18.3417085427 | 7.96 | 13.985 | 5.9 | 816196 | 8.84230809 | CS |
| 52 | -21.84 | -77.0642201835 | 28.34 | 29.31 | 5.9 | 914249 | 12.26118678 | CS |
| 156 | -2.51 | -27.8579356271 | 9.01 | 30.99 | 2.19 | 658790 | 12.54990437 | CS |
| 260 | 4.67 | 255.191256831 | 1.83 | 30.99 | 0.3511 | 715123 | 8.57698211 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
